Experts believe a wider spat with Europe would be much more damaging than the current tit-for-tat with China.Traderead more
After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
Markets pay particular attention to Italy's spending, given its public debt pile. This stands at above 130% of its growth rate, one of the highest in the world.Politicsread more
Office phones, printers, building control systems and more — these may not sound like computers but they can all be hacked according to cybersecurity pros.Technologyread more
Software stocks are the place to be in tech as the sector mounts a recovery from its recent pullback, some analysts say.Trading Nationread more
Flight bookings to Hong Kong have fallen 10%, hit by the unrest in the city, said Alan Joyce, the chief executive of Australian carrier Qantas Airways.Airlinesread more
South Korea will scrap an intelligence-sharing pact with Japan amid an intensifying dispute over history and trade, South Korea's presidential office said on Thursday.Asia Politicsread more
Analysts generally doubt how effective the People Bank of China's latest interest rate announcement will be in significantly helping businesses grow.China Economyread more
Toyota's revolutionary approach to manufacturing turned it from a tiny Japanese automotive latecomer into one of the biggest car companies in the world. But its designs have...Autosread more
These in-demand skills can command top pay packets, says Feon Ang of professional networking site LinkedIn.Get Aheadread more
The recent criticism surrounding Theranos, a privately held diagnostics company valued at about $9 billion, has been unfair, Theranos board member Richard Kovacevich said Monday.
He was responding to a series of Wall Street Journal reports raising questions about the accuracy of the proprietary method from Theranos — designed to conduct lab tests using only a small finger prick instead of drawing blood the traditional way with needles. The company stands by its claims, and CEO Elizabeth Holmes defended the work on CNBC in October.
"I think it's very, very unfortunate what's happening to Theranos. I think it's very unfair. I believe in Elizabeth and what she's doing," Kovacevich told CNBC's "Squawk Box " on Monday. "I think time will tell that [Theranos] truly is revolutionizing the diagnostic business."
Kovacevich, former Wells Fargo chairman and CEO, is among the power players on the Theranos board, which also includes former Secretary of State Henry Kissinger, epidemiologist and ex-CDC Director William Foege, as well as former Senate Majority Leader Bill Frist, who is also a heart and lung transplant surgeon.
Addressing critics who claim there should be more board members from the medical field, Kovacevich said: "Most boards don't have scientists on them quite frankly. The scientists are internal and outside consultants." Though he did point to Frist, Foege, as well as mathematician and engineer William Perry who also served as defense secretary under President Bill Clinton, as examples.
Touted as the world's youngest female billionaire, Holmes founded Palo Alto, California-based Theranos in 2003. She was just 19 years old. A year later, she dropped out of Stanford University. Holmes has raised more than $400 million in funding, and she owns 50 percent of the company.